RU2011116852A - METHOD FOR FORECASTING DEVELOPMENT OF MALIGNANT OR UTERINE UTERINE PATHOLOGY - Google Patents
METHOD FOR FORECASTING DEVELOPMENT OF MALIGNANT OR UTERINE UTERINE PATHOLOGY Download PDFInfo
- Publication number
- RU2011116852A RU2011116852A RU2011116852/15A RU2011116852A RU2011116852A RU 2011116852 A RU2011116852 A RU 2011116852A RU 2011116852/15 A RU2011116852/15 A RU 2011116852/15A RU 2011116852 A RU2011116852 A RU 2011116852A RU 2011116852 A RU2011116852 A RU 2011116852A
- Authority
- RU
- Russia
- Prior art keywords
- uterine
- tissue
- development
- testosterone
- malignant
- Prior art date
Links
Abstract
Способ прогнозирования развития злокачественной или доброкачественной патологии матки, включающий биохимическое исследование, отличающийся тем, что у менопаузальных женщин с гиперпластичным типом эндометрия при наличии жалоб на кровомазание проводят диагностическое выскабливание, определяют содержание в эндометрии прогестерона и тестостерона и при уровнях прогестерона от 2,0 до 7,0 нг/г ткани и тестостерона от 4,0 до 8,8 нг/г ткани прогнозируют развитие рака эндометрия, а при уровнях прогестерона 24,0-29,6 нг/г ткани и тестостерона от 16,8 до 22,4 нг/г ткани прогнозируют развитие миомы матки. A method for predicting the development of malignant or benign uterine pathology, including a biochemical study, characterized in that in menopausal women with a hyperplastic type of the endometrium, in the presence of complaints of hemorrhage, diagnostic curettage is carried out, the content of progesterone and testosterone in the endometrium is determined, and at progesterone levels from 2.0 to 7 , 0 ng / g of tissue and testosterone from 4.0 to 8.8 ng / g of tissue predict the development of endometrial cancer, and at progesterone levels of 24.0-29.6 ng / g of tissue and testosterone from 16.8 to 22.4ng / g of tissue predicts the development of uterine fibroids.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2011116852/15A RU2484473C2 (en) | 2011-04-27 | 2011-04-27 | Method for prediction of developing malignant and benign uterine pathology |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2011116852/15A RU2484473C2 (en) | 2011-04-27 | 2011-04-27 | Method for prediction of developing malignant and benign uterine pathology |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2011116852A true RU2011116852A (en) | 2012-11-10 |
| RU2484473C2 RU2484473C2 (en) | 2013-06-10 |
Family
ID=47321837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011116852/15A RU2484473C2 (en) | 2011-04-27 | 2011-04-27 | Method for prediction of developing malignant and benign uterine pathology |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2484473C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2561677C1 (en) * | 2014-06-19 | 2015-08-27 | Федеральное государственное бюджетное учреждение "Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации | Method of differential diagnostics of highly differentiated endometrioid adenocarcinoma of corpus uteri in patients of perimenopausal period |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2018835C1 (en) * | 1990-11-11 | 1994-08-30 | Гаркави Любовь Хаимовна | Method of prognosis of oncologic disease course |
| RU2395097C1 (en) * | 2008-10-21 | 2010-07-20 | Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Росмедтехнологий" | Method of prognosis of disease course in patients with uterine body cancer |
| RU2466390C2 (en) * | 2011-02-15 | 2012-11-10 | Государственное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения и социального развития Российской Федерации (ГОУ ВПО Первый МГМУ им. И.М. Сеченова Минздравсоцразвития России) | Method for prediction of developing endometrial cancer in pathological endometrial processes in females of reproductive age |
-
2011
- 2011-04-27 RU RU2011116852/15A patent/RU2484473C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2484473C2 (en) | 2013-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Werner et al. | ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas | |
| EA201290716A1 (en) | METHODS AND COMPOSITIONS FOR NONINVASIVE PRENATAL DIAGNOSTICS OF FETUS ANEUPLOIDY | |
| Zhang et al. | Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma | |
| Mari-Alexandre et al. | MicroRNAs and angiogenesis in endometriosis | |
| ME01123B (en) | Pregesterone antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc | |
| Suman et al. | Leukemia inhibitory factor increases the invasiveness of trophoblastic cells through integrated increase in the expression of adhesion molecules and pappalysin 1 with a concomitant decrease in the expression of tissue inhibitor of matrix metalloproteinases | |
| Köbel et al. | Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study | |
| WO2010099137A3 (en) | In situ methods for monitoring the emt status of tumor cells in vivo | |
| Song et al. | Risk factors for the progression or persistence of untreated mild dysplasia of the uterine cervix | |
| WO2015136509A3 (en) | Diagnostic and therapeutic targets for preeclampsia and closely related complications of pregnancy | |
| RU2009120957A (en) | METHOD FOR EARLY DIAGNOSIS OF THE FACING THREAT CONDITION | |
| NZ729773A (en) | Biomarkers for disease progression in melanoma | |
| WO2013074044A8 (en) | Methods for diagnosis and/or prognosis of gynecological cancer | |
| Terek et al. | Paratubal borderline tumor diagnosed in the adolescent period: a case report and review of the literature | |
| RU2011116852A (en) | METHOD FOR FORECASTING DEVELOPMENT OF MALIGNANT OR UTERINE UTERINE PATHOLOGY | |
| Tiwari et al. | Modulation of E-Cadherin and N-Cadherin by ovarian steroids and embryonic stimuli | |
| RU2011105301A (en) | METHOD FOR FORECASTING UTERINE BODY CANCER DEVELOPMENT IN PATHOLOGICAL ENDOMETRY PROCESSES IN REPRODUCTIVE WOMEN | |
| Neri et al. | Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases | |
| MA38465A1 (en) | Dosage form of the progesterone receptor antagonist | |
| Guzińska-Ustymowicz et al. | Expression of phosphatase of regenerating liver-3 (PRL-3) in endometrioid cancer and lymph nodes metastases | |
| UA86478U (en) | Method for treating syndrome of chronic pelvic pain in genital endometriosis | |
| UA44056U (en) | Method for prediction of antenatal distress of fetus at carried pregnancy | |
| RU2009140816A (en) | METHOD FOR FORECASTING ANTENATAL DEATH OF THE FRUIT | |
| RU2013116097A (en) | METHOD FOR DIAGNOSIS OF UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIS IN WOMEN WITH A LAST PREGNANCY LOSS | |
| Liu et al. | Modified IHC4 score predicts prognosis but not chemotherapy survival benefit in young women with HR-positive, HER2-negative early breast cancer: A Hospital-Based Cohort study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20140428 |